UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000047401
Receipt No. R000054060
Scientific Title Stratification of psychiatric disorders by eye tracking
Date of disclosure of the study information 2022/04/05
Last modified on 2022/10/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Stratification of psychiatric disorders by eye tracking
Acronym Stratification of psychiatric disorders by eye tracking
Scientific Title Stratification of psychiatric disorders by eye tracking
Scientific Title:Acronym Stratification of psychiatric disorders by eye tracking
Region
Japan

Condition
Condition psychiatric disorders
Classification by specialty
Psychiatry Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is the stratification of psychiatric disorders by eye tracking.
Basic objectives2 Others
Basic objectives -Others The aim of this study is the stratification of psychiatric disorders by eye tracking.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary endpoints are diagnosis, clinical evaluation, and cognitive function.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria psychiatric disorder group
1, schizophrenia, mood disorder, anxiety disorder, developmental disorder, dementia, organic psychiatric disorder
2, Over 20 years old

healthy control group
1, Healthy subjects with no history of mental illness
2, Over 20 years old
Key exclusion criteria 1, With a serious physical illness
2, The case who was judged as inappropriate for register by researcher
Target sample size 1400

Research contact person
Name of lead principal investigator
1st name Jinichi
Middle name
Last name Hirano
Organization Keio University
Division name Department of Neuropsychiatry, Keio University School of medicine
Zip code 160-8582
Address 35 Shinanomachi Shinjuku-ku,Tokyo, Japan
TEL +81-3-3353-1211
Email hjinichi@gmail.com

Public contact
Name of contact person
1st name Jinichi
Middle name
Last name Hirano
Organization Keio University
Division name Department of Neuropsychiatry, Keio University School of medicine
Zip code 160-8582
Address 35 Shinanomachi Shinjuku-ku,Tokyo, Japan
TEL +81-3-3353-1211
Homepage URL
Email hjinichi@gmail.com

Sponsor
Institute Keio University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The ethics committe of the Keio University School of Medicine
Address 35 Shinanomachi Shinjuku-ku,Tokyo, Japan
Tel :03-5363-3503
Email med-rinri-jimu@adst.keio.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 04 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 04 Month 26 Day
Date of IRB
2021 Year 04 Month 26 Day
Anticipated trial start date
2022 Year 04 Month 06 Day
Last follow-up date
2026 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This study evaluates eye tracking (free viewing, saccade pursuit, etc.), mental status, and medical information and stratifies the psychiatric disorder using these metrics.

Management information
Registered date
2022 Year 04 Month 05 Day
Last modified on
2022 Year 10 Month 08 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054060